
USD
+$0.00
(+0.00%
)At Close (As of Oct 24, 2025)
$2.98B
Market Cap
-
P/E Ratio
-11.71
EPS
$103.00
52 Week High
$12.76
52 Week Low
HEALTHCARE
Sector
| Field | Value (USD) |
|---|---|
| Gross Profit | -$78M |
| Total Revenue | $126M |
| Cost Of Revenue | $204M |
| Costof Goods And Services Sold | $204M |
| Operating Income | -$2.2B |
| Selling General And Administrative | $187M |
| Research And Development | $322M |
| Operating Expenses | $2.1B |
| Investment Income Net | - |
| Net Interest Income | $27M |
| Interest Income | $27M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $158M |
| Income Before Tax | -$2.2B |
| Income Tax Expense | -$135M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$2B |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$768M |
| Ebitda | -$610M |
| Net Income | -$2B |
| Field | Value (USD) |
|---|---|
| Total Assets | $3B |
| Total Current Assets | $820M |
| Cash And Cash Equivalents At Carrying Value | $214M |
| Cash And Short Term Investments | $214M |
| Inventory | $19M |
| Current Net Receivables | $25M |
| Total Non Current Assets | $2.2B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $2B |
| Intangible Assets Excluding Goodwill | $2B |
| Goodwill | $0 |
| Investments | - |
| Long Term Investments | - |
| Short Term Investments | $549M |
| Other Current Assets | $13M |
| Other Non Current Assets | - |
| Total Liabilities | $480M |
| Total Current Liabilities | $77M |
| Current Accounts Payable | $4.8M |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $13M |
| Total Non Current Liabilities | $403M |
| Capital Lease Obligations | $68M |
| Long Term Debt | - |
| Current Long Term Debt | - |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $68M |
| Other Current Liabilities | $57M |
| Other Non Current Liabilities | $2.2M |
| Total Shareholder Equity | $2.5B |
| Treasury Stock | - |
| Retained Earnings | -$9.8B |
| Common Stock | $34K |
| Common Stock Shares Outstanding | $32M |
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$577M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $158M |
| Capital Expenditures | $5.2M |
| Change In Receivables | - |
| Change In Inventory | $3.1M |
| Profit Loss | - |
| Cashflow From Investment | -$551M |
| Cashflow From Financing | $1.2B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$2B |
| Field | Value (USD) |
|---|---|
| Gross Profit | -$78M |
| Total Revenue | $126M |
| Cost Of Revenue | $204M |
| Costof Goods And Services Sold | $204M |
| Operating Income | -$2.2B |
| Selling General And Administrative | $187M |
| Research And Development | $322M |
| Operating Expenses | $2.1B |
| Investment Income Net | - |
| Net Interest Income | $27M |
| Interest Income | $27M |
| Interest Expense | - |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $158M |
| Income Before Tax | -$2.2B |
| Income Tax Expense | -$135M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$2B |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$768M |
| Ebitda | -$610M |
| Net Income | -$2B |
Sector: HEALTHCARE
Industry: DIAGNOSTICS & RESEARCH
None